Episode Details
Back to Episodes
Key Considerations of Gene Therapy Development: A Caregiver's Story
Published 1 month, 2 weeks ago
Description
Emily Walsh Martin, PhD, spoke with Amber Freed, founder and CEO of SLC6A1 Connect, a patient organization focused on accelerating the development of therapies for SLC6A1 patients like her son Maxwell.
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.